Spire Healthcare Group (LON:SPI) Stock Price Up 9.1% – Time to Buy?

Shares of Spire Healthcare Group plc (LON:SPI) shot up 9.1% during trading on Friday . The company traded as high as GBX 242.61 ($3.08) and last traded at GBX 239.50 ($3.04). 1,545,344 shares were traded during trading, an increase of 187% from the average session volume of 537,597 shares. The stock had previously closed at GBX 219.50 ($2.79).

Analyst Ratings Changes

Separately, Berenberg Bank restated a “buy” rating and issued a GBX 300 ($3.81) price objective on shares of Spire Healthcare Group in a research note on Tuesday, September 17th.

Spire Healthcare Group Price Performance

The company has a quick ratio of 0.74, a current ratio of 0.70 and a debt-to-equity ratio of 169.51. The firm has a market cap of £961.09 million, a price-to-earnings ratio of 3,135.71, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96. The stock’s 50-day moving average price is GBX 223.86 and its 200 day moving average price is GBX 239.38.

Insiders Place Their Bets

In related news, insider Justin Ash bought 21,100 shares of the company’s stock in a transaction dated Tuesday, September 17th. The stock was acquired at an average cost of GBX 236 ($3.00) per share, with a total value of £49,796 ($63,208.94). Corporate insiders own 34.71% of the company’s stock.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.